Donoghue Forlines’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,134
Closed -$1.48M 268
2024
Q3
$1.48M Buy
+4,134
New +$1.48M 0.42% 67
2021
Q3
Sell
-3,342
Closed -$600K 244
2021
Q2
$600K Sell
3,342
-112
-3% -$20.1K 0.11% 172
2021
Q1
$578K Sell
3,454
-519
-13% -$86.9K 0.11% 176
2020
Q4
$603K Buy
+3,973
New +$603K 0.12% 190